UK implants review is a chance to restore confidence in EU device regulation
This article was originally published in Clinica
The upcoming review of the EU medical device directives has attracted more than usual interest among the general public in the wake of health scares surrounding the use of medical implants – fake or failing.
You may also be interested in...
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.
How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.
2019 saw fewer revenue-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.